A comparative study of the effect of systemic and intratympanic corticosteroid treatment in improving vestibular tests in patients with sudden sensorineural hearing loss SSNHL with vestibular disorders
Determining and comparing the effect of systemic and intratympanic corticosteroid treatment in improving balance tests in SSNHL patients with balance disorders
Design
Clinical trial with control group, with parallel groups, without blinding, randomized, phase 2 on 40 patients. A table of random numbers was used for randomization.
Settings and conduct
This clinical trial will be conducted in 1402 in Kashani hospital in Isfahan city. People will be randomly divided into two groups. Oral treatment with prednisolone is at a dose of 1 mg per kilogram of body weight per day and with a maximum of 60 mg, which is done for 7 days and then stopped. Intratympanic treatment is in the form of injecting one ampoule of methylprednisolone once every other day up to 3 times. The time to start the treatment immediately after the diagnosis of the disease is at most 72 hours after the sensation of sudden hearing loss. Blinding was not done in this study.
Participants/Inclusion and exclusion criteria
This study is conducted on people with SSNHL who meet the inclusion criteria including unilateral symptoms and informed consent and do not have exclusion criteria such as underlying problems and bilateral symptoms.
Intervention groups
group under intratympanic treatment and group under systemic treatment. Oral treatment with prednisolone is at a dose of 1 mg per kilogram of body weight per day and with a maximum of 60 mg, which is done for 7 days and then stopped. Intratympanic treatment is in the form of injecting one ampoule of methylprednisolone once every other day up to 3 times. The time to start the treatment immediately after the diagnosis of the disease is at most 72 hours after the sensation of sudden hearing loss.
Main outcome variables
vestibular function
General information
Reason for update
Acronym
IRCT registration information
IRCT registration number:IRCT20230721058871N1
Registration date:2023-07-27, 1402/05/05
Registration timing:prospective
Last update:2023-07-27, 1402/05/05
Update count:0
Registration date
2023-07-27, 1402/05/05
Registrant information
Name
rouhallah Mohammadi
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 938 512 2176
Email address
mohammadimuq@gmail.com
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2023-08-23, 1402/06/01
Expected recruitment end date
2023-09-23, 1402/07/01
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
A comparative study of the effect of systemic and intratympanic corticosteroid treatment in improving vestibular tests in patients with sudden sensorineural hearing loss SSNHL with vestibular disorders
Public title
systemic and intratympanic corticosteroid treatment in sensorineural hearing loss
neurological conditions
bilateral
unable to perform tests
Age
From 18 years old to 70 years old
Gender
Both
Phase
2-3
Groups that have been masked
No information
Sample size
Target sample size:
40
Randomization (investigator's opinion)
Randomized
Randomization description
Randomization was done with the help of a table of random numbers and in a simple way. In this way, according to the number of participants in the study, the researcher puts his finger on a table number and moves up and left and generates random numbers. Then, based on the sample size of the research, a number of envelopes with aluminum wrappers, preparation and each of the random sequences created are recorded on a card and the cards are placed inside the envelopes in order. In order to maintain a random sequence, the outer surface of the envelopes is numbered in the same order. Finally, the lid of the letter envelopes is glued and placed in a box. At the time of registration of the participants, based on the order of entry of eligible participants into the study, one of the envelopes will be opened and the assigned group of that participant will be revealed. If the number is odd, the person is placed in the first group, and if the number is even, the person is placed in the second group.
Blinding (investigator's opinion)
Not blinded
Blinding description
Placebo
Not used
Assignment
Parallel
Other design features
Secondary Ids
empty
Ethics committees
1
Ethics committee
Name of ethics committee
Ethics committee of Isfahan University of Medical Sciences
Street address
Hezar Jarib
City
isfahan
Province
Isfehan
Postal code
۸۱۷۴۶۷۳۴۶۱
Approval date
2023-06-25, 1402/04/04
Ethics committee reference number
IR.MUI.MED.REC.1402.122
Health conditions studied
1
Description of health condition studied
sudden sensorineural hearing loss
ICD-10 code
H90.5
ICD-10 code description
Unspecified sensorineural hearing loss
Primary outcomes
1
Description
Vestibular function
Timepoint
Before treatment and 6 weeks later
Method of measurement
cervical vestibular evoked myogenic potential
Secondary outcomes
empty
Intervention groups
1
Description
Intervention group: Systemic treatment. Oral treatment with prednisolone is at a dose of 1 mg per kilogram of body weight per day and with a maximum of 60 mg, which is done for 7 days and then stopped.
Category
Treatment - Drugs
2
Description
Intervention group: Intertympanic group. Intratympanic treatment is in the form of injecting one ampoule of methylprednisolone once every other day up to 3 times.
Category
Treatment - Drugs
Recruitment centers
1
Recruitment center
Name of recruitment center
Kashani hospital
Full name of responsible person
Rouhallah Mohammadi
Street address
kashani street, Kashani hospital
City
Isfahan
Province
Isfehan
Postal code
8174673461
Phone
+98 31 3668 0048
Email
mohammadimuq@gmail.com
Sponsors / Funding sources
1
Sponsor
Name of organization / entity
Esfahan University of Medical Sciences
Full name of responsible person
Gholamreza Asgari
Street address
Hezar Jarib
City
Isfahan
Province
Isfehan
Postal code
8174673461
Phone
+98 31 3668 0048
Email
askari@mui.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Esfahan University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic
Person responsible for general inquiries
Contact
Name of organization / entity
Esfahan University of Medical Sciences
Full name of responsible person
Rouhallah Mohammadi
Position
resident
Latest degree
Medical doctor
Other areas of specialty/work
Ear, Nose, and Throat
Street address
Hezar Jarib
City
Isfahan
Province
Isfehan
Postal code
8174673461
Phone
+98 31 3668 0048
Email
mohammadimuq@gmail.com
Person responsible for scientific inquiries
Contact
Name of organization / entity
Esfahan University of Medical Sciences
Full name of responsible person
Rouhallah Mohammadi
Position
resident
Latest degree
Medical doctor
Other areas of specialty/work
Ear, Nose, and Throat
Street address
Hezar Jarib
City
Isfahan
Province
Isfehan
Postal code
8174673461
Phone
+98 31 3668 4800
Email
mohammadimuq@gmail.com
Person responsible for updating data
Contact
Name of organization / entity
Esfahan University of Medical Sciences
Full name of responsible person
rouhallah mohammadi
Position
resident
Latest degree
Medical doctor
Other areas of specialty/work
Ear, Nose, and Throat
Street address
Hezar jarib
City
Isfahan
Province
Isfehan
Postal code
۸۱۷۴۶۷۳۴۶۱
Phone
0098316680048
Email
mohammadimuq@gmail.com
Sharing plan
Deidentified Individual Participant Data Set (IPD)
No - There is not a plan to make this available
Justification/reason for indecision/not sharing IPD